AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11327442
Drug: Zidovudine plus
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine plus zalcitabine (200 mg zidovudine three times daily + 0.75 mg zalcitabine three times daily)
Trial: 11327442
Drug: Zidovudine monotherapy
RxNorm normalized name: Zidovudine
DrugBank: Zidovudine (DB00495)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zidovudine monotherapy (200 mg three times daily)
Trial: 8434265
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education message and antimalarial drug intervention 1
Trial: 8434265
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education message and antimalarial drug intervention 2
Trial: 8434265
Drug: Health education
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health education message and antimalarial drug intervention 3
Trial: 3315267
Drug: Treatment A
RxNorm normalized name: Nix Ultra Lice Treatment And Prevention Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment A - 8 mg/kg at 0700 hr and 4 mg/kg at 1900 hr
Trial: 3315267
Drug: Treatment B
RxNorm normalized name: PanOxyl Acne Treatment Bar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment B - 6 mg/kg at 0700 hr and 6 mg/kg at 1900 hr
Trial: 3315267
Drug: Treatment C
RxNorm normalized name: Acne Treatment Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment C - 4 mg/kg at 0700 hr and 8 mg/kg at 1900 hr
Trial: 30917809
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group without bleaching treatment
Trial: 28272596
Drug: Pharmacists obtaining
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacists obtaining admission medication histories (AMHs)
Trial: 24485339
Drug: 5% sucrose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% sucrose solution
Trial: 24485339
Drug: Aspartate solution
RxNorm normalized name: aspartate
DrugBank: Potassium aspartate (DB15819)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspartate solution
Trial: 24485339
Drug: Cortisol levels
RxNorm normalized name: cortisol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol levels after all treatments (sucrose, aspartate, placebo)
Trial: 15486840
Drug: Conventional report
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional report + written alert + oral clinical advice (Group C)
Trial: 20350251
Drug: Alpha-tocopherol 50
RxNorm normalized name: (+)-alpha-tocopherol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-tocopherol 50 mg/day
Trial: 20350251
Drug: Beta-carotene 20
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene 20 mg/day
Trial: 7931205
Drug: Desipramine blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desipramine blood levels above 123 ng/ml at week 2
Trial: 3203062
Drug: Inhaled PAF
RxNorm normalized name: pafuramidine
DrugBank: Pafuramidine (DB06532)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled PAF
Trial: 19040036
Drug: Healive (inactivated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healive (inactivated hepatitis A vaccine)
Trial: 12866325
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide aqueous (TAA AQ) 200 micrograms once daily (n = 75)
Trial: 12866325
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate aqueous (BDP) 336 micrograms twice daily (n = 77)
Trial: 10783825
Drug: Erythromycin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (2 g)
Trial: 6743479
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg once‐daily)
Trial: 3534594
Drug: Additional chemotherapy
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional chemotherapy with alternate drugs after completion of FAC
Trial: 26637514
Drug: Eribulin mesylate
RxNorm normalized name: Eribulin Mesylate
DrugBank: Eribulin (DB08871)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Eribulin mesylate 1.4 mg/m² as a two‐ to five‐minute i.v. infusion on days 1 and 8 of a 21‐day cycle
Trial: 24189290
Drug: CapOpus (motivational
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CapOpus (motivational interviewing and cognitive behavior therapy)
Trial: 16798652
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of deferiprone (L1) daily plus desferrioxamine (DFO) twice weekly
Trial: 19456797
Drug: Betamethasone 17-valerate
RxNorm normalized name: Cortisol 17-valerate
DrugBank: Hydrocortisone valerate (DB14544)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone 17-valerate 0.1% cream
Trial: 11273943
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg hyperbaric tetracaine
Trial: 11273943
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg hyperbaric tetracaine, 10 microg fentanyl, and 0.2 mg epinephrine
Trial: 11273943
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg hyperbaric tetracaine, 10 microg fentanyl, and 0.2 mL saline
Trial: 8387662
Drug: Naltrexone 50
RxNorm normalized name: naltrexone 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naltrexone 50 mg (pretreatment)
Trial: 3475987
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose droperidol (0.25 mg)
Trial: 3475987
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose droperidol (0.5 mg)
Trial: 21402650
Drug: Basic Body
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic Body Awareness Therapy for seven weeks
Trial: 14733349
Drug: Extracorporeal shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shock wave treatments (ESW)
Trial: 10657406
Drug: GV150526 (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GV150526 (800 mg loading dose followed by 200 mg every 12 hours for 3 days)
Trial: 8422658
Drug: Oral physostigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral physostigmine (OP) 16 mg/day for 6 weeks
Trial: 3020227
Drug: Pindolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (10 mg q.i.d.)
Trial: 3020227
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg q.i.d.)
Trial: 27289163
Drug: Meal containing
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meal containing 10 g of extra virgin olive oil (EVOO)
Trial: 25281778
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg solifenacin daily
Trial: 21499206
Drug: Secretin (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secretin (16 μg administered intravenously before ERCP)
Trial: 17293736
Drug: Implantable cardioverter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable cardioverter defibrillator therapy in patients with NYHA class II HF
Trial: 17293736
Drug: Implantable cardioverter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable cardioverter defibrillator therapy in patients with NYHA class III HF
Trial: 17293736
Drug: Amiodarone drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amiodarone drug therapy in patients with NYHA class III HF
Trial: 15228214
Drug: Ingestion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingestion of beta‐conglycinin (5 g daily)
Trial: 7870963
Drug: Active gum
RxNorm normalized name: STANNOUS FLUORIDE 1.1 mg in 1 g DENTAL PASTE [parodontax Active Gum Repair]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active gum + active patch (double active)
Trial: 7870963
Drug: Active gum
RxNorm normalized name: STANNOUS FLUORIDE 1.1 mg in 1 g DENTAL PASTE [parodontax Active Gum Repair]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active gum + placebo patch (gum only active)
Trial: 7870963
Drug: Placebo gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gum + active patch (patch active)
Trial: 7870963
Drug: Placebo gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo gum + placebo patch (double placebo)
Trial: 30541604
Drug: Thread-embedding acupuncture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thread-embedding acupuncture (TEA), administered once every 2 weeks for 8 weeks (4 sessions total)
Trial: 30541604
Drug: Acupuncture, administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture, administered twice per week for 8 weeks (16 sessions total)
Trial: 22078221
Drug: Fibrinolysis treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolysis treatment in women
Trial: 22078221
Drug: Fibrinolysis treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolysis treatment in men
Trial: 22078221
Drug: Fibrinolysis treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolysis treatment in women with bleeding
Trial: 22078221
Drug: Fibrinolysis treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolysis treatment in men with bleeding
Trial: 22078221
Drug: Fibrinolysis treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolysis treatment in women without bleeding
Trial: 22078221
Drug: Fibrinolysis treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinolysis treatment in men without bleeding
Trial: 19852962
Drug: TMC435 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMC435 200 mg once daily for 5 days (patients)
Trial: 19852962
Drug: TMC435 (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMC435 (various doses) in healthy volunteers
Trial: 19852962
Drug: TMC435 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMC435 200 mg twice daily or 100, 200, or 400 mg once daily (healthy volunteers)
Trial: 17038828
Drug: Respiratory route
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respiratory route of measles vaccine administration
Trial: 17038828
Drug: Respiratory route
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respiratory route of measles vaccine administration (for vaccinees over 9 months of age)
Trial: 17038828
Drug: Respiratory route
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Respiratory route of measles vaccine administration (Edmonston Zagreb strain)
Trial: 17038828
Drug: Aerosolized EZ
RxNorm normalized name: Jock-Eze
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosolized EZ vaccine
Trial: 7485344
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no antibiotic therapy)
Trial: 6840161
Drug: Cadralazine (ISF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cadralazine (ISF 2469) 7.5 mg
Trial: 6840161
Drug: Cadralazine (ISF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cadralazine (ISF 2469) 15 mg
Trial: 6840161
Drug: Cadralazine (ISF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cadralazine (ISF 2469) 20 mg
Trial: 6840161
Drug: Cadralazine (ISF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cadralazine (ISF 2469) 30 mg
Trial: 19016798
Drug: Omalizumab (Xolair)
RxNorm normalized name: Omalizumab
DrugBank: Omalizumab (DB00043)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Omalizumab (Xolair) in combination with depigmented SIT (Depigoid)
Trial: 11350520
Drug: Braun Oral‐B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral‐B D9
Trial: 3591956
Drug: 150 g
RxNorm normalized name: TOCOPHEROL 2 g in 150 g TOPICAL OIL [TUREMRIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 g protein, 30 g fat, and 30 g carbohydrate (P)
Trial: 3591956
Drug: 150 g
RxNorm normalized name: TOCOPHEROL 2 g in 150 g TOPICAL OIL [TUREMRIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 g carbohydrate, 30 g fat, and 30 g protein (C)
Trial: 2660991
Drug: Aspirin with
RxNorm normalized name: Bayer Aspirin with Calcium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin with dipyridamole
Trial: 18972076
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of Systane Lubricant Eye Drops
Trial: 14727703
Drug: Polymer gel
RxNorm normalized name: dicresulene polymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polymer gel sock in conjunction with the removable rigid dressing
Trial: 10378544
Drug: Inhaled salmeterol
RxNorm normalized name: salmeterol Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled salmeterol (42 microg per actuation)
Trial: 10378544
Drug: Extended-release oral
RxNorm normalized name: Carbinoxamine Maleate Extended-Release Oral Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release oral theophylline (titrated to serum levels of 10 to 20 microg/mL)
Trial: 8681669
Drug: High-dose fenoterol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose fenoterol (5 mg)
Trial: 8681669
Drug: Low-dose fenoterol
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose fenoterol (1 mg)
Trial: 7924541
Drug: Nonpharmacologic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonpharmacologic therapy
Trial: 6143849
Drug: Corgard (nadolol)
RxNorm normalized name: nadolol Oral Tablet [Corgard]
DrugBank: Nadolol (DB01203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Corgard (nadolol) 80 mg
Trial: 27036991
Drug: Tenofovir alafenamide
RxNorm normalized name: Tenofovir Alafenamide
DrugBank: Tenofovir alafenamide (DB09299)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tenofovir alafenamide (200 mg emtricitabine with 10 mg or 25 mg tenofovir alafenamide)
Trial: 27036991
Drug: Tenofovir disoproxil
RxNorm normalized name: Tenofovir Disoproxil
DrugBank: Tenofovir disoproxil (DB00300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tenofovir disoproxil fumarate (200 mg emtricitabine with 200 mg or 300 mg tenofovir disoproxil fumarate)
Trial: 20192914
Drug: Chromium picolinate
RxNorm normalized name: Chromium Picolinate
DrugBank: Chromium picolinate (DB11255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chromium picolinate (1000 microg daily)
Trial: 12071996
Drug: 10% cocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% cocaine spray
Trial: 7611550
Drug: Primaquine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine (0.5 mg/kg every other day for 16-19 weeks)
Trial: 7611550
Drug: Chloroquine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (5 mg/kg weekly for 16-19 weeks)
Trial: 21717823
Drug: Program A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Program A (modified US Department of Agriculture food pyramid diet and rice protein powder supplement)
Trial: 12621482
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy plus stem-cell transplantation
Trial: 9126306
Drug: Granisetron, methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron, methylprednisolone (250 mg/body), and droperidol (0.5 ml/body)
Trial: 8471555
Drug: Sequential methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sequential methotrexate (250 mg/m2) and 5-fluorouracil (500 mg/m2) followed by leucovorin (15 mg x 8) (MFL)
Trial: 8471555
Drug: Sequential 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential 5-fluorouracil (500 mg/m2) followed by leucovorin (60 mg/m2) (FLv)
Trial: 2956392
Drug: 15 mmol
RxNorm normalized name: dibasic potassium phosphate 15 MMOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mmol sodium/day (plus frusemide, 40 mg on day 1)
Trial: 30267987
Drug: Ixabepilone (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ixabepilone (40 mg/m2)
Trial: 15913717
Drug: Rectal measurement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal measurement of intra-abdominal pressure (Prec)
Trial: 10198865
Drug: Cooled intraocular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cooled intraocular irrigating solution (approximately 10 degrees C)
Trial: 10198865
Drug: Room temperature
RxNorm normalized name: ROOM DEODORIZER POWDER MENTOR #3202
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Room temperature irrigating solution
Trial: 2180471
Drug: multidrug chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: multidrug chemotherapy (MDC)
Trial: 31123069
Drug: Low-sodium peritoneal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-sodium peritoneal dialysis fluid (125 mmol/L Na)
Trial: 31123069
Drug: Standard-sodium peritoneal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-sodium peritoneal dialysis fluid (134 mmol/L Na)
Trial: 28104097
Drug: 5% NaHCO3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% NaHCO3 and distilled water solution at 40-45°C
Trial: 17177056
Drug: Albendazole (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (15 mg/kg/day for 2 weeks)
Trial: 22185963
Drug: HX575 (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HX575 (subcutaneous administration)
Trial: 20685806
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (transcranial direct current stimulation and visual illusion)
Trial: 18204328
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of AT
Trial: 7737266
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg/day for at least 1 year
Trial: 7737266
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (lipid-lowering diet only)
Trial: 2405735
Drug: pH-adjusted bupivacaine
RxNorm normalized name: PH-284
DrugBank: PH-284 (DB05452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pH-adjusted bupivacaine with hyaluronidase 15 units/ml (pH 6.82 +/‐ 0.09)
Trial: 18173093
Drug: Xylitol (6.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylitol (6.2 g/day)
Trial: 8018401
Drug: Cisplatin-based chemotherapy
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin-based chemotherapy with doxorubicin
Trial: 8018401
Drug: Cisplatin-based chemotherapy
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin-based chemotherapy without doxorubicin
Trial: 2644855
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ferrous sulfate twice daily for 16 weeks
Trial: 1115173
Drug: Non-steroid IUD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-steroid IUD
Trial: 28035868
Drug: Sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100 mg once daily for 24 weeks
Trial: 23639513
Drug: Olmesartan/Amlodipine fixed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan/Amlodipine fixed-dose combination (OA)
Trial: 23639513
Drug: Amlodipine double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine double dose (DA)
Trial: 12716247
Drug: Lithium augmentation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium augmentation (LA)
Trial: 3900975
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg q.o.d.)
Trial: 3900975
Drug: Beta-carotene (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (50 mg q.o.d.)
Trial: 27311399
Drug: Intensity Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity Modulated Radiation Therapy (IMRT) with level V lymphatics (LVN) included
Trial: 27311399
Drug: Intensity Modulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity Modulated Radiation Therapy (IMRT) with level V lymphatics (LVN) omitted
Trial: 18005381
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia with 20 ml levobupivacaine 0.625 mg/ml and fentanyl 2 microg/ml
Trial: 16099291
Drug: C4A-rich plasma
RxNorm normalized name: Platelet Rich Plasma
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C4A-rich plasma priming (20 mL/kg)
Trial: 16099291
Drug: C4A-free plasma
RxNorm normalized name: Antihemophilic factor recombinant plasma/albumin free
DrugBank: Moroctocog alfa (DB13999)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: C4A-free plasma priming (20 mL/kg)
Trial: 11868640
Drug: Birth weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Birth weight 4000 g or more
Trial: 8732492
Drug: L-lysine
RxNorm normalized name: L-Lysine
DrugBank: Lysine (DB00123)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: L-lysine
Trial: 1553671
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg trinitroglycerine patches
Trial: 31087715
Drug: Any antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any antibiotics use